Although AFP is one of the best standards for detection of HCC, AFP has limited utility for detecting HCC [14], suggesting that a combined assay of AFP, DCP, and AFP-L3 would be recommended as a follow-up for patients with chronic liver diseases. Here, AFP is linked to hepatocellular carcinoma.